Human papillomavirus (HPV) has emerged as a driving cause of head and neck cancer, but investigations outside the West are limited. A p16 immunohistochemistry is a commonly used biomarker for HPV cancers. We sought to investigate the pathology and rates of HPV head and neck oropharyngeal cancer in Japan via p16 immunohistochemistry at 2 institutions in Japan.
Methods:
Fifty-nine oropharyngeal specimens from 2 university hospitals in Japan were examined for morphology and p16 immunohistochemistry. The rate of p16 positivity was then determined, and the 2 groups were compared for differences in age, smoking history, gender, and stage of presentation and mortality.
Results:
The rate of p16 positivity among the oropharyngeal specimens was 29.5%. There were important differences in the pathology compared to morphology usually seen in the US. The patients with p16+ cancer tended to be younger. There was no significant difference in smoking status. Patients with p16+ cancers trended toward better survival.
Conclusion:
There appears to be a geographical difference in HPV rates of oropharyngeal cancers with persistently lower rates in Asian countries when compared to Western Europe and the US. Conclusions about HPV head and neck squamous cell carcinoma (HNSCC) in Western countries may not be generalizable across the globe at this time.
FerlayJSoerjomataramIDikshitR. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2015;136(5):E359-E386.
2.
MarurSD’SouzaGWestraWHForastiereAA.HPV-associated head and neck cancer: a virus-related cancer epidemic. Lancet Oncol. 2010;11(8):781-789.
3.
ShinAJungYSJungKWKimKRyuJWonYJ.Trends of human papillomavirus-related head and neck cancers in Korea: national cancer registry data. Laryngoscope. 2013;123(11):E30-E37.
4.
Johnson-ObasekiSMcDonaldJTCorstenMRourkeR.Head and neck cancer in Canada: trends 1992 to 2007. Otolaryngol Head Neck Surg. 2012;147(1):74-78.
5.
SnowANLaudadioJ.Human papillomavirus detection in head and neck squamous cell carcinomas. Adv Anat Pathol. 2010;17(6):394-403.
6.
ErnsterJASciottoCGO’BrienMM. Rising incidence of oropharyngeal cancer and the role of oncogenic human papilloma virus. Laryngoscope. 2007;117(12):2115-2128.
7.
ShiboskiCHSchmidtBLJordanRC.Tongue and tonsil carcinoma: increasing trends in the U.S. population ages 20-44 years. Cancer. 2005;103(9):1843-1849.
8.
KreimerARCliffordGMBoylePFranceschiS.Human papillomavirus types in head and neck squamous cell carcinomas worldwide: a systematic review. Cancer Epidemiol Biomarkers Prev. 2005;14(2):467-475.
9.
CuradoMPHashibeM.Recent changes in the epidemiology of head and neck cancer. Curr Opin Oncol. 2009;21(3):194-200.
10.
GillisonMLKochWMCaponeRB. Evidence for a causal association between human papillomavirus and a subset of head and neck cancers. J Natl Cancer Inst. 2000;92(9):709-720.
11.
SyrjanenKSyrjanenSLambergMPyrhonenSNuutinenJ.Morphological and immunohistochemical evidence suggesting human papillomavirus (HPV) involvement in oral squamous cell carcinogenesis. Int J Oral Surg. 1983;12(6):418-424.
12.
MirghaniHAmenFMoreauF. Human papilloma virus testing in oropharyngeal squamous cell carcinoma: what the clinician should know. Oral Oncol. 2014;50(1):1-9.
13.
MehannaHBeechTNicholsonT. Prevalence of human papillomavirus in oropharyngeal and nonoropharyngeal head and neck cancer—systematic review and meta-analysis of trends by time and region. Head Neck. 2013;35(5):747-755.
14.
PanwarABatraRLydiattWMGantiAK.Human papilloma virus positive oropharyngeal squamous cell carcinoma: a growing epidemic. Cancer Treat Rev. 2014;40(2):215-219.
15.
EvansMNewcombeRFianderA. Human papillomavirus-associated oropharyngeal cancer: an observational study of diagnosis, prevalence and prognosis in a UK population. BMC Cancer. 2013;13:220.
16.
RischinDYoungRJFisherR. Prognostic significance of p16INK4A and human papillomavirus in patients with oropharyngeal cancer treated on TROG 02.02 phase III trial. J Clin Oncol. 2010;28(27):4142-4148.
17.
HabbousSChuKPQiuX. The changing incidence of human papillomavirus-associated oropharyngeal cancer using multiple imputation from 2000 to 2010 at a Comprehensive Cancer Centre. Cancer Epidemiol. 2013;37(6):820-829.
18.
WangMBLiuIYGornbeinJANguyenCT.HPV-positive oropharyngeal carcinoma: a systematic review of treatment and prognosis. Otolaryngol Head Neck Surg. 2015;153(5):758-769.
19.
NasmanAAttnerPHammarstedtL. Incidence of human papillomavirus (HPV) positive tonsillar carcinoma in Stockholm, Sweden: an epidemic of viral-induced carcinoma?Int J Cancer. 2009;125(2):362-366.
20.
SinghiADWestraWH.Comparison of human papillomavirus in situ hybridization and p16 immunohistochemistry in the detection of human papillomavirus-associated head and neck cancer based on a prospective clinical experience. Cancer. 2010;116(9):2166-2173.
21.
GondimDDHaynesWWangXChernockRDEl-MoftySKLewisJSJr. Histologic Typing in oropharyngeal squamous cell carcinoma: a 4-year prospective practice study with p16 and high-risk HPV mRNA testing correlation. Am J Surg Pathol. 2016;40(8):1117-1124.
22.
BlombergMNielsenAMunkCKjaerSK.Trends in head and neck cancer incidence in Denmark, 1978-2007: focus on human papillomavirus associated sites. Int J Cancer. 2011;129(3):733-741.
23.
HwangTZHsiaoJRTsaiCRChangJS.Incidence trends of human papillomavirus-related head and neck cancer in Taiwan, 1995-2009. Int J Cancer. 2015;137(2):395-408.
24.
LiWThompsonCHXinD. Absence of human papillomavirus in tonsillar squamous cell carcinomas from Chinese patients. Am J Pathol. 2003;163(6):2185-2189.
25.
ChienCYSuCYFangFM. Lower prevalence but favorable survival for human papillomavirus-related squamous cell carcinoma of tonsil in Taiwan. Oral Oncol. 2008;44(2):174-179.
26.
HamaTTokumaruYFujiiM. Prevalence of human papillomavirus in oropharyngeal cancer: a multicenter study in Japan. Oncology. 2014;87(3):173-182.
27.
NomuraFSugimotoTKitagakiK. Clinical characteristics of Japanese oropharyngeal squamous cell carcinoma positive for human papillomavirus infection. Acta Otolaryngol. 2014;134(12):1265-1274.
28.
SaitoYYoshidaMOmuraG. Prognostic value of p16 expression irrespective of human papillomavirus status in patients with oropharyngeal carcinoma. Jpn J Clin Oncol. 2015;45(9):828-836.
29.
KawakamiHOkamotoITeraoK. Human papillomavirus DNA and p16 expression in Japanese patients with oropharyngeal squamous cell carcinoma. Cancer Med. 2013;2(6):933-941.
30.
SchlechtNFBrandwein-GenslerMNuovoGJ. A comparison of clinically utilized human papillomavirus detection methods in head and neck cancer. Mod Pathol. 2011;24(10):1295-1305.
31.
BegumSWestraWH.Basaloid squamous cell carcinoma of the head and neck is a mixed variant that can be further resolved by HPV status. Am J Surg Pathol. 2008;32(7):1044-1050.
32.
KraneJF.Role of cytology in the diagnosis and management of HPV-associated head and neck carcinoma. Acta Cytol. 2013;57(2):117-126.
33.
JoVYMillsSEStolerMHStelowEB.Papillary squamous cell carcinoma of the head and neck: frequent association with human papillomavirus infection and invasive carcinoma. Am J Surg Pathol. 2009;33(11):1720-1724.
34.
RaginCCTaioliE.Survival of squamous cell carcinoma of the head and neck in relation to human papillomavirus infection: review and meta-analysis. Int J Cancer. 2007;121(8):1813-1820.
35.
MelkaneAEMirghaniHAuperinA. HPV-related oropharyngeal squamous cell carcinomas: a comparison between three diagnostic approaches. Am J Otolaryngol. 2014;35(1):25-32.
